202 related articles for article (PubMed ID: 28471199)
1. [Zinc-modified Nanotransporter for Target Drug Therapy of Breast Cancer].
Skaličková S; Gargulák M; Löffelmann M; Ruttkay-Nedecký B; Kepinská M; Parák T; Kizek R
Klin Onkol; 2017; 30(Supplementum1):174-176. PubMed ID: 28471199
[TBL] [Abstract][Full Text] [Related]
2. [Fullerene Doxorubicin Nanotransporter for Target Interaction with mutated gene BRCA2].
Skaličková S; Löfelmann M; Gargulák M; Dočekalová M; Ruttkay-Nedecký B; Suchý P; Kepinská M; Kizek R
Klin Onkol; 2017; 30(Supplementum1):177-179. PubMed ID: 28471200
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-Modified Apoferritin Nanotransfer for Targeted Cytostatic Transport.
Čížek M; Gargulák M; Sehnal K; Uhlířová D; Staňková M; Dočekalová M; Ruttkay-Nedecký B; Zídková J; Kizek R
Klin Onkol; 2019; 32(3):197-200. PubMed ID: 31216851
[TBL] [Abstract][Full Text] [Related]
4. Zinc Modified Nanotransporter of Anticancer Drugs for Targeted Therapy: Biophysical Analysis.
Skalickova S; Docekalova M; Stankova M; Uhlirova D; Ruttkay-Nedecky B; Fernandez C; Kepinska M; Milnerowicz H; Kizek R
J Nanosci Nanotechnol; 2019 May; 19(5):2483-2488. PubMed ID: 30501743
[TBL] [Abstract][Full Text] [Related]
5. Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery.
Skalickova S; Loffelmann M; Gargulak M; Kepinska M; Docekalova M; Uhlirova D; Stankova M; Fernandez C; Milnerowicz H; Ruttkay-Nedecky B; Kizek R
Nanomaterials (Basel); 2017 Dec; 7(12):. PubMed ID: 29292780
[TBL] [Abstract][Full Text] [Related]
6. Folic acid magnetic nanotheranostics for delivering doxorubicin: Toxicological and biocompatibility studies on Zebrafish embryo and larvae.
Igartúa DE; Azcona PL; Martinez CS; Alonso SDV; Lassalle VL; Prieto MJ
Toxicol Appl Pharmacol; 2018 Nov; 358():23-34. PubMed ID: 30205093
[TBL] [Abstract][Full Text] [Related]
7. pH-responsive delivery of doxorubicin from citrate-apatite nanocrystals with tailored carbonate content.
Rodríguez-Ruiz I; Delgado-López JM; Durán-Olivencia MA; Iafisco M; Tampieri A; Colangelo D; Prat M; Gómez-Morales J
Langmuir; 2013 Jul; 29(26):8213-21. PubMed ID: 23735159
[TBL] [Abstract][Full Text] [Related]
8. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
11. Towards the development of multifunctional chitosan-based iron oxide nanoparticles: Optimization and modelling of doxorubicin release.
Soares PIP; Sousa AI; Ferreira IMM; Novo CMM; Borges JP
Carbohydr Polym; 2016 Nov; 153():212-221. PubMed ID: 27561489
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
[TBL] [Abstract][Full Text] [Related]
13. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy.
Bisht S; Maitra A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):415-25. PubMed ID: 20049807
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles.
Wang X; Zhen X; Wang J; Zhang J; Wu W; Jiang X
Biomaterials; 2013 Jun; 34(19):4667-79. PubMed ID: 23537667
[TBL] [Abstract][Full Text] [Related]
15. SChitosan-capped gold nanoparticles impair radioresistant glioblastoma stem-like cells.
Aldea M; Potara M; Soritau O; Stefan Florian I; Florea A; Nagy-Simon T; Pileczki V; Brie I; Maniu D; Kacso G
J BUON; 2018; 23(3):800-813. PubMed ID: 30003755
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model.
Kratz F; Azab S; Zeisig R; Fichtner I; Warnecke A
Int J Pharm; 2013 Jan; 441(1-2):499-506. PubMed ID: 23149257
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
[TBL] [Abstract][Full Text] [Related]
18. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
19. Zinc Gluconate-Loaded Chitosan Nanoparticles Reduce Severity of Collagen-Induced Arthritis in Wistar Rats.
Ansari MM; Ahmad A; Mishra RK; Raza SS; Khan R
ACS Biomater Sci Eng; 2019 Jul; 5(7):3380-3397. PubMed ID: 33405580
[TBL] [Abstract][Full Text] [Related]
20. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
